Useless Peer Review?

A study shows that the methods by which scientists evaluate each other’s work are error-prone and poor at measuring merit.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, EUROPEAN SOUTHERN OBSERVATORYScientific publications are regularly evaluated by post-publication peer review, number of citations, and impact factor (IF) of the journal in which they are published. But research evaluating these three methods, published in PLOS Biology last week (October 8), found that they do a poor job of measuring scientific merit. “Scientists are probably the best judges of science, but they are pretty bad at it,” said first author Adam Eyre-Walker of the University of Sussex in the U.K. in a statement.

Eyre-Walker and coauthor Nina Stoletzki of Hannover, Germany, analyzed post-publication peer review databases from Faculty of 1000 (F1000) and the Wellcome Trust, containing 5,811 and 716 papers respectively. In each of these databases, reviewers assigned subjective scores to papers based on merit. Eyre-Walker and Stoletzki expected that papers of similar merit would get similar scores, but they found that the reviewers assigned papers the same scores about half the time—only slightly more often than expected by chance. The researchers also found a strong correlation between the IF of the journal in which papers were published and the merit scores that reviewers assigned to papers.

“Overall, it seems that subjective assessments of science are poor; they do not correlate strongly to each other and they appear ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies